Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia

Autor:	Stephen Holding, Sujoy Khan, David Allsup, Senthilkumar Durairaj, Punyarat Phumphukhieo
Rok vydání:	2021
Předmět:	Cancer Research Chronic lymphocytic leukemia Disease Secondary lymphoid organs 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Piperidines immune system diseases Agammaglobulinemia hemic and lymphatic diseases medicine Humans neoplasms Protein Kinase Inhibitors business.industry Adenine Hematology medicine.disease Leukemia Lymphocytic Chronic B-Cell Leukemia medicine.anatomical_structure Pyrimidines Oncology chemistry 030220 oncology & carcinogenesis Ibrutinib Cancer research Pyrazoles Bone marrow business 030215 immunology
Zdroj:	Leukemialymphoma. 62(7)
ISSN:	1029-2403
Popis:	Chronic lymphocytic leukemia (CLL) is characterized by a clonal expansion of CD5 + B cells in the bone marrow and secondary lymphoid organs. More than 75% of patients with CLL develop hypogammaglob...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839ee1e7bc98412d58a5112af78df70f https://pubmed.ncbi.nlm.nih.gov/33596758 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.